Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2024
∙
ACIP
ACIP Evidence to Recommendations Framework
2024
∙
Folkhälsomyndigheten
Health economic evaluation of varicella vaccination within the Swedish national vaccination program for children
2024
Updated recommendations for mpox vaccination in Spain
2024
∙
Haute Autorité de Santé
Transition of INFLUVAC influenza vaccine from its quadrivalent form to a trivalent form in the seasonal influenza vaccination strategy in France
2024
∙
NACI
Recommendations on the use of pneumococcal vaccines in adults, including PNEU-C-21
2024
∙
ACIP
New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024
2024
∙
JCVI
Flu vaccines 2025 to 2026: JCVI advice
2024
∙
JCVI
Shingles (herpes zoster) vaccination programme: JCVI statement, November 2024
2024
∙
JCVI
COVID-19 vaccination in 2025 and spring 2026: JCVI advice
2024
∙
ATAGI
ATAGI Clinical Guidance on the use of vaccines for the prevention of Mpox
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register